scispace - formally typeset
I

Inderpaul Singh Sehgal

Researcher at Post Graduate Institute of Medical Education and Research

Publications -  280
Citations -  3721

Inderpaul Singh Sehgal is an academic researcher from Post Graduate Institute of Medical Education and Research. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 213 publications receiving 2069 citations.

Papers
More filters
Journal ArticleDOI

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.

Deepak Garg, +8 more
- 05 Feb 2021 - 
TL;DR: In this article, a case of probable pulmonary mucormycosis in a 55-year-old man with diabetes, end-stage kidney disease, and COVID-19 associated pulmonary aspergillosis was described.
Journal ArticleDOI

Foreign Body Inhalation in the Adult Population: Experience of 25,998 Bronchoscopies and Systematic Review of the Literature

Inderpaul Singh Sehgal, +7 more
- 01 Oct 2015 - 
TL;DR: Flexible bronchoscopy has a high success rate in removal of inhaled foreign body and can be considered the preferred initial procedure for management of airway foreign bodies in adults.
Journal ArticleDOI

Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis

Ritesh Agarwal, +3 more
- 07 Nov 2016 - 
TL;DR: The current evidence in the evaluation and treatment of this enigmatic disorder is summarized and modifications to the existing criteria are suggested and a new scoring system for the diagnosis of ABPA is proposed.
Journal ArticleDOI

Diagnostic Performance of Xpert MTB/RIF in Tuberculous Pleural Effusion: Systematic Review and Meta-analysis

Inderpaul Singh Sehgal, +4 more
- 01 Apr 2016 - 
TL;DR: Xpert MTB/RIF has low sensitivity but excellent specificity in the diagnosis of TPE.
Journal ArticleDOI

A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma

Ritesh Agarwal, +7 more
- 01 Feb 2016 - 
TL;DR: Medium-dose oral glucocorticoids are as effective and safer than high-dose in treatment of ABPA, and composite response rates were significantly higher in the high- dose group, improvement in lung function and time to first exacerbation were similar in the two groups.